These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12026217)

  • 1. Study of the complexation behavior of tenoxicam with cyclodextrins in solution: improved solubility and percutaneous permeability.
    Larrucea E; Arellano A; Santoyo S; Ygartua P
    Drug Dev Ind Pharm; 2002 Mar; 28(3):245-52. PubMed ID: 12026217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin.
    Larrucea E; Arellano A; Santoyo S; Ygartua P
    Eur J Pharm Biopharm; 2001 Sep; 52(2):113-9. PubMed ID: 11522475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of tenoxicam with cyclodextrins and its influence on the in vitro percutaneous penetration of the drug.
    Larrucea E; Arellano A; Santoyo S; Ygartua P
    Drug Dev Ind Pharm; 2001; 27(3):251-60. PubMed ID: 11291205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin.
    Gwak HS; Chun IK
    Int J Pharm; 2002 Apr; 236(1-2):57-64. PubMed ID: 11891070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of piroxicam: hydroxypropyl-beta-cyclodextrin complexation on the in vitro permeation and skin retention of piroxicam.
    Doliwa A; Santoyo S; Ygartua P
    Skin Pharmacol Appl Skin Physiol; 2001; 14(2):97-107. PubMed ID: 11316968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
    Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of beta-cyclodextrins on the permeation of diclofenac from supersaturated solutions.
    Dias MM; Raghavan SL; Pellett MA; Hadgraft J
    Int J Pharm; 2003 Sep; 263(1-2):173-81. PubMed ID: 12954192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal lontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes.
    Doliwa A; Santoyo S; Ygartua P
    Drug Dev Ind Pharm; 2001 Sep; 27(8):751-8. PubMed ID: 11699826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of solubilization and complexation characteristics for new antifungal compound with cyclodextrins. Impact of cyclodextrins on distribution process.
    Volkova TV; Perlovich GL
    Eur J Pharm Sci; 2020 Nov; 154():105531. PubMed ID: 32871213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug.
    Aloisio C; Gomes de Oliveira A; Longhi M
    Drug Dev Ind Pharm; 2014 Jul; 40(7):919-28. PubMed ID: 23627444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclodextrins on the solubility and stability of a novel soft corticosteroid, loteprednol etabonate.
    Bodor N; Drustrup J; Wu W
    Pharmazie; 2000 Mar; 55(3):206-9. PubMed ID: 10756542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicomponent complexes of piroxicam with cyclodextrins and hydroxypropyl methylcellulose.
    Jug M; Bećirević-Laćan M
    Drug Dev Ind Pharm; 2004; 30(10):1051-60. PubMed ID: 15595571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
    Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
    Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cyclodextrin complexation on piroxicam gel formulations.
    Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
    Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetics and molecular modeling of the complexation of tenoxicam with cyclodextrins in solution.
    Rawashdeh A; Mizyed S; Mahmoud S; Marji D
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(2):562-5. PubMed ID: 18289928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
    Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
    Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
    Stojanov M; Nielsen HM; Larsen KL
    Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cyclodextrins on the aqueous solubility of a new MMP inhibitor: phase solubility, 1 H-NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solutions.
    Bertholet P; Gueders M; Dive G; Albert A; Barillaro V; Perly B; Cataldo D; Piel G; Delattre L; Evrard B
    J Pharm Pharm Sci; 2005 Jul; 8(2):163-74. PubMed ID: 16124927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous absorption and model membrane variations of melatonin in aqueous-based propylene glycol and 2-hydroxypropyl-beta-cyclodextrin vehicles.
    Lee BJ; Cui JH; Parrott KA; Ayres JW; Sack RL
    Arch Pharm Res; 1998 Oct; 21(5):503-7. PubMed ID: 9875485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nonionic surfactants on the percutaneous absorption tenoxicam.
    Endo M; Yamamoto T; Ijuin T
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):865-7. PubMed ID: 8681419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.